Effect of hyperbaric oxygen therapy on diabetes-related oral complications.

Background: Diabetes Mellitus is a chronic disease characterized by uncontrolled blood sugar levels, which lead to end-organ damage. While the diagnosis and treatment of its complications have been extensively studied, the effect of Hyperbaric Oxygen Therapy (HBO ₂ ) on diabetes-related oral complications remains unexplored.
Aim: This prospective clinical study aims to investigate the effect of HBO ₂ on diabetes-related oral complications.
Methods: Twenty patients diagnosed with diabetic foot ulcers and scheduled for HBO ₂ were included in this study. We recorded stimulated and unstimulated saliva pH, buffering capacity, flow rate, and subjective symptoms such as dry mouth, halitosis, taste loss, difficulty swallowing, and clinical examination findings before HBO ₂ and after the 21st session.
Results: Upon comparing the findings, we observed a significant decrease in dry mouth and halitosis, periodontal disease severity, and healing of candida-related stomatitis and angular cheilitis. Despite not reaching statistical significance for other saliva parameters, the unstimulated salivary flow rate increased to normal limits (0.3-0.4 ml/min) in 6 out of 8 patients with a flow rate of less than 0.25 ml/min.
Conclusion: Our study investigated the effect of HBO ₂ on diabetes-related oral complications for the first time, highlighting symptomatic relief for dry mouth and halitosis. Although our results are insufficient to report a definitive benefit, they underscore the need for further research on the oral health effects of HBO ₂ .
Competing Interests: The authors of this paper declare no conflicts of interest exist with this submission.
(Copyright© Undersea and Hyperbaric Medical Society.)